UTMD
Utah Medical Products Inc
NASDAQ: UTMD · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$65.42
+0.60% today
Updated 2026-04-30
Market cap
$207.06M
P/E ratio
19.24
P/S ratio
5.52x
EPS (TTM)
$3.38
Dividend yield
1.85%
52W range
$51 – $72
Volume
0.0M
Utah Medical Products Inc (UTMD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
28.90%
Operating margin
29.40%
ROE
9.14%
ROA
6.16%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $28.75M | $8.17M | 56.16% | 37.68% | 28.41% |
| 2007 | $28.50M | $7.91M | 55.39% | 37.74% | 27.73% |
| 2008 | $27.78M | $7.21M | 54.06% | 37.39% | 25.93% |
| 2009 | $25.92M | $6.26M | 53.21% | 36.39% | 24.15% |
| 2010 | $25.12M | $6.01M | 52.59% | 35.52% | 23.94% |
| 2011 | $37.86M | $7.41M | 59.17% | 31.28% | 19.58% |
| 2012 | $41.55M | $10.17M | 60.90% | 36.57% | 24.47% |
| 2013 | $40.49M | $11.41M | 59.94% | 36.62% | 28.17% |
| 2014 | $41.28M | $11.38M | 60.52% | 39.25% | 27.56% |
| 2015 | $40.16M | $11.84M | 60.23% | 38.97% | 29.49% |
| 2016 | $39.30M | $12.13M | 60.28% | 41.19% | 30.86% |
| 2017 | $41.41M | $8.51M | 63.73% | 45.90% | 20.54% |
| 2018 | $42.00M | $18.55M | 62.64% | 44.52% | 44.18% |
| 2019 | $46.90M | $14.73M | 62.82% | 37.59% | 31.40% |
| 2020 | $42.18M | $10.80M | 60.57% | 32.50% | 25.60% |
| 2021 | $49.05M | $14.79M | 63.03% | 38.49% | 30.15% |
| 2022 | $52.28M | $16.47M | 61.58% | 37.85% | 31.51% |
| 2023 | $50.22M | $16.64M | 59.81% | 33.40% | 33.12% |
| 2024 | $40.90M | $13.87M | 59.03% | 33.23% | 33.92% |
| 2025 | $38.52M | $11.29M | 51.60% | 29.60% | 29.30% |